221 results Stibbe advises on the acquisition of an Intercontinental hotel portfolio including the landmark Amstel Hotel in Amsterdam Stibbe advised Katara Hospitality QSA (a subsidiary of the Qatar Investment Authority), the Qatar-based global owner, developer and operator of hotels, on the acquisition of five luxury InterContinental properties in key European cities. Stibbe advises Aedifica Stibbe advised Aedifica recently on two transactions in order to further expand her Dutch portfolio of care assets. Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of a care residence that will be constructed in Leersum. Aedifica acquired the full property of the site from Woudenburcht B.V., a local real estate developer. See for the press release here. Stibbe represents Simed in dispute with Slotervaart hospital Stibbe represented Simed International in a dispute with the privately-owned Slotervaart hospital in Amsterdam. The Slotervaart hospital claimed that Simed International had sent incorrect invoices to the Slotervaart hospital, which would therefore have b Stibbe advises US asset manager Stibbe advised a US asset manager on securing the acquisition of a real estate portfolio in France via a Luxembourg, non-regulated fund platform. Stibbe advises The Blackstone Group Stibbe advises The Blackstone Group. Stibbe advises client in the pharmaceutical sector Stibbe assisted a client in the pharmaceutical sector with conducting an in-depth legal assessment regarding the scope and modalities of the safety features to be added to (the packaging of) medicinal products. Stibbe advises Merin (formerly Uni-Invest) Advising Merin (formerly Uni-Invest) on the restructuring of its of its approximately EUR 790 million outstanding CMBS and Mezzanine loans and the sale of the company to Patron Capital and TPG Capital. Stibbe advises leading US car rental company Stibbe advised a leading US car rental company on Luxembourg company law aspects related to its acquisition of PSA Peugeot Citroën’s car rental subsidiary, Citer SA and its Spanish subsidiary Atesa through a Luxembourg structure. Stibbe advises Forbion Capital Partners Advising Forbion Capital Partners on the delisting of Amsterdam Molecular Therapeutics (AMT) Holding. Stibbe advises the Port of Antwerp Stibbe advised the Port of Antwerp International on its strategic partnership with Essar Ports Ltd. which is India’s second largest private sector ports operator, and on PAI's investment into EPL. Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products. Stibbe advises on the contemplated IPO of Agendia Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products. Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency. Stibbe advises on the IPO of Tornier Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix. The New Luxembourg SFDR and Taxonomy Regulation Implementing Law On 3 March 2022, the Luxembourg law of 25 February 2022 implementing a.o. the Sustainable Finance Disclosure Regulation (SFDR) and the Taxonomy Regulation has been published in the Official Journal of the Grand Duchy of Luxembourg. Pagination Previous page Page 10 Current page 11 Page 12 Page 13 Next page
Stibbe advises on the acquisition of an Intercontinental hotel portfolio including the landmark Amstel Hotel in Amsterdam Stibbe advised Katara Hospitality QSA (a subsidiary of the Qatar Investment Authority), the Qatar-based global owner, developer and operator of hotels, on the acquisition of five luxury InterContinental properties in key European cities.
Stibbe advises Aedifica Stibbe advised Aedifica recently on two transactions in order to further expand her Dutch portfolio of care assets.
Stibbe advises Aedifica Stibbe advises Aedifica on the acquisition of a care residence that will be constructed in Leersum. Aedifica acquired the full property of the site from Woudenburcht B.V., a local real estate developer. See for the press release here.
Stibbe represents Simed in dispute with Slotervaart hospital Stibbe represented Simed International in a dispute with the privately-owned Slotervaart hospital in Amsterdam. The Slotervaart hospital claimed that Simed International had sent incorrect invoices to the Slotervaart hospital, which would therefore have b
Stibbe advises US asset manager Stibbe advised a US asset manager on securing the acquisition of a real estate portfolio in France via a Luxembourg, non-regulated fund platform.
Stibbe advises client in the pharmaceutical sector Stibbe assisted a client in the pharmaceutical sector with conducting an in-depth legal assessment regarding the scope and modalities of the safety features to be added to (the packaging of) medicinal products.
Stibbe advises Merin (formerly Uni-Invest) Advising Merin (formerly Uni-Invest) on the restructuring of its of its approximately EUR 790 million outstanding CMBS and Mezzanine loans and the sale of the company to Patron Capital and TPG Capital.
Stibbe advises leading US car rental company Stibbe advised a leading US car rental company on Luxembourg company law aspects related to its acquisition of PSA Peugeot Citroën’s car rental subsidiary, Citer SA and its Spanish subsidiary Atesa through a Luxembourg structure.
Stibbe advises Forbion Capital Partners Advising Forbion Capital Partners on the delisting of Amsterdam Molecular Therapeutics (AMT) Holding.
Stibbe advises the Port of Antwerp Stibbe advised the Port of Antwerp International on its strategic partnership with Essar Ports Ltd. which is India’s second largest private sector ports operator, and on PAI's investment into EPL.
Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products.
Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.
Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency.
Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix.
The New Luxembourg SFDR and Taxonomy Regulation Implementing Law On 3 March 2022, the Luxembourg law of 25 February 2022 implementing a.o. the Sustainable Finance Disclosure Regulation (SFDR) and the Taxonomy Regulation has been published in the Official Journal of the Grand Duchy of Luxembourg.